Alaunos Therapeutics (TCRT) Short Interest Ratio & Short Volume → The asset beating inflation by 4x (From Colonial Metals) (Ad) Free TCRT Stock Alerts $1.30 -0.06 (-4.41%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Alaunos Therapeutics Short Interest DataCurrent Short Volume1,460,000 sharesPrevious Short Volume1,520,000 sharesChange Vs. Previous Month-3.95%Dollar Volume Sold Short$2.04 millionShort Interest Ratio / Days to Cover12.5Last Record DateApril 15, 2024Outstanding Shares16,010,000 sharesFloat Size15,360,000 sharesShort Percent of Float9.51%Today's Trading Volume25,343 sharesAverage Trading Volume176,771 sharesToday's Volume Vs. Average14% Short Selling Alaunos Therapeutics ? Sign up to receive the latest short interest report for Alaunos Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTCRT Short Interest Over TimeTCRT Days to Cover Over TimeTCRT Percentage of Float Shorted Over Time Ad Paradigm PressDems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. Alaunos Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,460,000 shares $2.04 million -4.0%9.5%12.5 $1.40 3/31/20241,520,000 shares $2.75 million -1.9%9.9%7.9 $1.81 3/15/20241,550,000 shares $2.65 million -6.1%10.1%6.4 $1.71 2/29/20241,650,000 shares $3.45 million -0.6%10.7%4.6 $2.09 2/15/20241,660,000 shares $2.64 million -2.9%10.8%4.3 $1.59 1/31/20241,710,000 shares $4.32 million -7.1%11.2%3.9 $2.53 Get the Latest News and Ratings for TCRT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202427,530,000 shares $4.45 million +1.9%12.0%4 $0.16 12/31/202327,020,000 shares $1.91 million +20.1%11.8%4.2 $0.07 12/15/202322,500,000 shares $1.02 million -5.0%9.8%4.5 $0.05 11/30/202323,690,000 shares $1.57 million +5.9%10.3%7.1 $0.07 11/15/202322,380,000 shares $1.68 million -6.9%9.7%7.2 $0.08 10/31/202324,040,000 shares $1.92 million +3.8%10.5%7.8 $0.08 10/15/202323,170,000 shares $2.55 million +0.0%10.1%9.8 $0.11 9/30/202323,160,000 shares $3.05 million -2.0%10.1%10.9 $0.13 9/15/202323,630,000 shares $2.98 million -2.7%10.3%11.7 $0.13 8/31/202324,290,000 shares $3.42 million -5.5%10.6%13.4 $0.14 8/15/202325,710,000 shares $3.57 million -1.6%11.2%14.9 $0.14 7/31/202326,140,000 shares $11.30 million +1.2%11.4%49.3 $0.43 7/15/202325,820,000 shares $12.14 million -0.1%11.8%48.4 $0.47 6/30/202325,840,000 shares $13.18 million +1.0%11.8%47.5 $0.51 6/15/202325,580,000 shares $12.28 million +2.5%11.7%45.9 $0.48 5/31/202324,950,000 shares $12.45 million +4.8%11.4%40.3 $0.50 5/15/202323,810,000 shares $15.48 million -0.3%11.0%38.1 $0.65 4/30/202323,880,000 shares $13.61 million +0.4%11.1%38.3 $0.57 4/15/202323,780,000 shares $13.55 million +1.2%11.0%35.9 $0.57 3/31/202323,500,000 shares $14.81 million +1.7%10.9%30.4 $0.63 3/15/202323,110,000 shares $11.50 million -1.9%10.7%24.6 $0.50 2/28/202323,560,000 shares $13.08 million +0.0%10.9%21.6 $0.56 2/15/202323,550,000 shares $15.07 million -2.2%10.9%17.6 $0.64 1/31/202324,090,000 shares $17.79 million -0.4%11.2%16.3 $0.74 1/15/202324,180,000 shares $19.28 million -7.3%11.1%15.7 $0.80 12/30/202226,070,000 shares $16.92 million -5.9%12.0%15.2 $0.65 12/15/202227,690,000 shares $17.05 million -11.5%12.8%14.1 $0.62 11/30/202231,290,000 shares $19.96 million -1.3%14.5%9.4 $0.64 11/15/202231,700,000 shares $32.33 million -1.4%16.2%8.6 $1.02 10/31/202232,160,000 shares $36.98 million +9.4%16.3%8.5 $1.15 10/15/202229,390,000 shares $32.04 million +1.1%14.9%7.5 $1.09 9/30/202229,070,000 shares $50.00 million +3.8%14.9%7.6 $1.72 9/15/202228,000,000 shares $59.08 million -3.6%14.4%6.8 $2.11 8/31/202229,050,000 shares $71.46 million +0.0%14.9%9 $2.46Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now TCRT Short Interest - Frequently Asked Questions What is Alaunos Therapeutics' current short interest? Short interest is the volume of Alaunos Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 1,460,000 shares of TCRT short. 9.51% of Alaunos Therapeutics' shares are currently sold short. Learn More on Alaunos Therapeutics' current short interest. What is a good short interest ratio for Alaunos Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TCRT shares currently have a short interest ratio of 12.0. Learn More on Alaunos Therapeutics's short interest ratio. What is a good short interest percentage for Alaunos Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.51% of Alaunos Therapeutics' floating shares are currently sold short. Is Alaunos Therapeutics' short interest increasing or decreasing? Alaunos Therapeutics saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 1,460,000 shares, a drop of 3.9% from the previous total of 1,520,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Alaunos Therapeutics' float size? Alaunos Therapeutics currently has issued a total of 16,010,000 shares. Some of Alaunos Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Alaunos Therapeutics currently has a public float of 15,360,000 shares. How does Alaunos Therapeutics' short interest compare to its competitors? 9.51% of Alaunos Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Alaunos Therapeutics: MEI Pharma, Inc. (0.34%), Sol-Gel Technologies Ltd. (0.10%), BioVie Inc. (2.78%), Synlogic, Inc. (0.53%), KALA BIO, Inc. (0.21%), Onconova Therapeutics, Inc. (0.12%), RenovoRx, Inc. (0.45%), Aptorum Group Limited (1.89%), Flora Growth Corp. (7.33%), Galecto, Inc. (0.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Alaunos Therapeutics stock? Short selling TCRT is an investing strategy that aims to generate trading profit from Alaunos Therapeutics as its price is falling. TCRT shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Alaunos Therapeutics? A short squeeze for Alaunos Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TCRT, which in turn drives the price of the stock up even further. How often is Alaunos Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TCRT, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: MEI Pharma Short Interest Sol-Gel Technologies Short Interest BioVie Short Interest Synlogic Short Interest KALA BIO Short Interest Onconova Therapeutics Short Interest RenovoRx Short Interest Aptorum Group Short Interest Flora Growth Short Interest Galecto Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TCRT) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldUrgent Nvidia WarningAltimetryAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGold ManiaStansberry ResearchThe Gold Grab of the CenturyColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmith